Develops genetic medicines for liver and lung diseases.
Dec 2025Revenue $4.63M/yrExpenses $213M/yr
No trendCash runway ≈ 7 months from Jun 2026
Figures by year
When will Prime Medicine be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $4.63M and expenses $213M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $4.63M | $213M | −$208M |
| Dec 2024 | $2.98M | $205M | −$202M |
| Dec 2023 | $0.00 | $205M | −$205M |
| Dec 2022 | $0.00 | $117M | −$117M |
| Dec 2021 | $0.00 | $84.5M | −$84.5M |
| Dec 2020 | $5.21M | $6.14M | −$932K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.